Trials / Completed
CompletedNCT04740515
Influence of a PPMTM on Adherence and Clinical Outcomes Among Preterm Infants With Iron Supplementation
Evaluation of the Influence of a Pharmacist-led Patient-Centered Medication Therapy Management on Adherence and Clinical Outcomes Among Preterm Infants With Iron Supplementation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 236 (actual)
- Sponsor
- Shaoxing Maternity and Child Health Care Hospital · Academic / Other
- Sex
- All
- Age
- 26 Weeks – 32 Weeks
- Healthy volunteers
- Not accepted
Summary
This is a randomised trial on the efficacy of a Pharmacist-led Patient-Centered Medication Therapy Management on clinical outcomes among preterm infants born before 32 weeks gestation with iron supplementation. The purpose of this study is to evaluate clinical outcome in the PPMTM program compared with usual care in an integrated health care system.
Detailed description
This is a randomised trial on the efficacy of a Pharmacist-led Patient-Centered Medication Therapy Management on clinical outcomes among preterm infants born before 32 weeks gestation with iron supplementation. As a result, the Committee on Nutrition of the American Academy of Pediatrics (AAP) recommends daily oral iron supplementation, of at least 2-4 mg/kg/day from 2 weeks of age, to prevent iron deficiency in extremely premature infants. The purpose of this study is to evaluate clinical outcome in the PPMTM program compared with usual care in an integrated health care system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | pharmacists involved PPMTM | This was an open labelled randomised study. Preterm Infants With iron supplementation were recruited and arbitrarily divided into the intervention group (usual care plus PPMTM) and the non-intervention group (usual care only). Those enrolled in the research were scheduled for follow-up for eight consecutive visits. Improvements in lab results and direct costs were compared longitudinally (pre and post analysis) between the groups. |
Timeline
- Start date
- 2022-02-15
- Primary completion
- 2022-02-21
- Completion
- 2023-08-08
- First posted
- 2021-02-05
- Last updated
- 2023-10-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04740515. Inclusion in this directory is not an endorsement.